Amgen Inc. (AMGN)

$ 374.75
   
  • Change Today:
    $-0.75
  • 52 Week High: $384.32
  • 52 Week Low: $262.28
  • Currency: US Dollars
  • Shares Issued: 538.80m
  • Volume: 2,911,602
  • Market Cap: $201,915m
  • RiskGrade: 100
  • Beta: 0.01

Latest ShareCast News

Amgen buys UK biotech Dark Blue Therapeutics for up to $840m

By Michele Maatouk

Date: Tuesday 06 Jan 2026

(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 374.75
Change Today $ -0.75
% Change -0.20 %
52 Week High $384.32
52 Week Low $262.28
Volume 2,911,602
Shares Issued 538.80m
Market Cap $201,915m
Beta 0.01
RiskGrade 100

What The Brokers Say

Strong Buy 7
Buy 8
Neutral 14
Sell 2
Strong Sell 1
Total 32
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 20-Feb-2026

Time Volume / Share Price
15:59 40 @ $374.75
15:59 60 @ $374.75
15:59 48 @ $374.66
15:59 100 @ $374.67
15:59 100 @ $374.68

Top of Page